AEVAW vs SRPT · rev $9.1M vs rev $1.13B
Aeva Technologies, Inc. Warrants (AEVAW) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Aeva Technologies, Inc. Warrants (AEVAW) is a software - infrastructure company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported AEVAW revenue for 2024-12-31 was $9.1M. Net income was -$152.3M. Revenue was up 110.2% from 2023-12-31 to 2024-12-31. AEVAW currently screens at market cap $0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
AEVAW currently screens at market cap $0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the AEVAW and SRPT stock pages for the full models.
Not investment advice.